Equity · Healthcare
HRMY
NASDAQHarmony Biosciences Holdings (HRMY)
The line runs 38 USD on 14 October through 33.56 USD on 10 November, on a scale from 32 to 40. Days the market did not trade hold the previous close, flat.
- Market cap
- 2.0B USD
- P/E (TTM)
- 11.1
- Revenue, year to Dec 2025
- 868.5M USD
- EPS, diluted, year to Dec 2025
- 2.71 USD
- 52-week range
- 26.87 USD – 41 USD
- Avg volume
- 132.9K
- Mentions, 30 days
- 1
as of Nov 10, 2026
Have Harmony Biosciences Holdings (HRMY) insiders bought or sold shares recently?
In the 90 days to 11 Nov 2026, Harmony Biosciences Holdings insiders reported 5 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 21 Nov 2025, show no open-market purchase.
Form 4, 90 days to 11 Nov 2026, newest reported trade 18 Sep 2026
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 18 Sep 2026 | Budur KumarCHIEF MEDICAL OFFICER | Sell | 35,852 | 1.5M USD |
| 17 Sep 2026 | Budur KumarCHIEF MEDICAL OFFICER | Sell | 800 | 34K USD |
| 16 Sep 2026 | Budur KumarCHIEF MEDICAL OFFICER | Sell | 1,800 | 77K USD |
| 08 Sep 2026 | Budur KumarCHIEF MEDICAL OFFICER | Sell | 28,454 | 1.2M USD |
| 04 Sep 2026 | Budur KumarCHIEF MEDICAL OFFICER | Sell | 5,500 | 231K USD |
| Sold | 5 open-market sales | 72,406 | $3.11M |
4 other filings in the window: grants, exercises, tax withholding and transfers, not trades
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 18 Sep 2026 | Budur KumarCHIEF MEDICAL OFFICER | Option exercise | 35,852 | 1.1M USD |
| 17 Sep 2026 | Budur KumarCHIEF MEDICAL OFFICER | Option exercise | 800 | 24K USD |
| 16 Sep 2026 | Budur KumarCHIEF MEDICAL OFFICER | Option exercise | 1,800 | 55K USD |
| 08 Sep 2026 | Budur KumarCHIEF MEDICAL OFFICER | Option exercise | 22,954 | 700K USD |
Which funds hold Harmony Biosciences Holdings (HRMY)?
9 of the 45 institutional funds we track reported a Harmony Biosciences Holdings position for the quarter ended 30 Jun 2026 — a combined 155.4M USD; the latest of those filings landed 02 Sep 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Renaissance Technologies | Held (±25%) | 1,195,371 | 43.5M USD | +11.0% |
| Two Sigma Investments | Added | 959,136 | 34.9M USD | +30.8% |
| AQR Capital Management | Added | 934,326 | 34.0M USD | +30.4% |
| Millennium Management | Trimmed | 319,812 | 11.6M USD | −66.5% |
| Citadel Advisors | Trimmed | 255,810 | 9.3M USD | −56.3% |
| Bridgewater Associates | Held (±25%) | 248,575 | 9.1M USD | −1.2% |
| Marshall Wace | Held (±25%) | 159,741 | 5.8M USD | +6.7% |
| Man Group | Trimmed | 142,443 | 5.2M USD | −69.2% |
| D. E. Shaw & Co. | Trimmed | 52,879 | 1.9M USD | −47.9% |
| Tudor Investment Corp | Exited |
What has been filed or recorded for Harmony Biosciences Holdings (HRMY)?
The filings we hold for Harmony Biosciences Holdings, newest first: 1 fails-to-deliver day, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 01 Oct 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 01 Oct 2026 | Fails to deliver | Shares failed to deliver | 940 shares | 37K USD notional · 0.002% of shares out |
| 30 Sep 2026 | Quarterly earnings | Q3 2026 reported | EPS 0.81 USD | Revenue $269M |
| 30 Sep 2026 | Financials | Total assets | 1.5B USD | at period end |
| 30 Sep 2026 | Financials | Total equity | 1.1B USD | at period end |
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS 1.28 USD | Revenue $261M |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS 0.55 USD | Revenue $215M |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS 2.71 USD | Revenue $868M |
| 31 Dec 2025 | Financials | Revenue | 868.5M USD | fiscal year |
| 31 Dec 2025 | Financials | Net income | 158.7M USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | 2.71 USD | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS 0.87 USD | Revenue $239M |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS 0.68 USD | Revenue $200M |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS 0.78 USD | Revenue $185M |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS 2.51 USD | Revenue $715M |
What is Reddit saying about Harmony Biosciences Holdings (HRMY)?
Reddit mentioned HRMY 1 times in the 30 days to 11 November 2026, in 1 of the communities we track. All of them were scored for sentiment: 100% read bullish, 0% bearish and 0% neither. Reddit data updated 11 November 2026.
30-day window, Method
How do Reddit mentions of Harmony Biosciences Holdings (HRMY) compare with its price?
Share ↗
Which subreddits are talking about Harmony Biosciences Holdings (HRMY)?
30 days
| Community | Share | Mentions | Net sentiment |
|---|---|---|---|
| r/wallstreetbets | 100% | 1 | +0.07 |
What do people ask about Harmony Biosciences Holdings (HRMY)?
What did Harmony Biosciences Holdings shares close at?33.56
Harmony Biosciences Holdings closed at 33.56 USD on 10 Nov 2026, down 0.71% on the close before. That is the end-of-day price from Finazon, not a live quote.
What is Harmony Biosciences Holdings’ market cap?2.0B
Harmony Biosciences Holdings is worth 2.0B USD by market value as of 10 Nov 2026, which is the share price times the shares on issue from its SEC filings.
What is Harmony Biosciences Holdings’ P/E ratio?11.1
Harmony Biosciences Holdings has a price-to-earnings ratio of 11.1, as of 10 Nov 2026: the share price divided by what the company earned per share over the last four reported quarters. A higher number means the market pays more for each dollar of earnings.
What is Harmony Biosciences Holdings’ revenue?868.5M
Harmony Biosciences Holdings reported revenue of 868.5M USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Have Harmony Biosciences Holdings insiders bought or sold shares recently?5 sales
In the 90 days to 11 Nov 2026, Harmony Biosciences Holdings insiders reported 5 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 21 Nov 2025, show no open-market purchase. A further 4 filings were grants, awards, gifts or exercises rather than open-market trades. See Insiders
Which funds own Harmony Biosciences Holdings?9 of 45
9 of the 45 funds we track reported a Harmony Biosciences Holdings position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were Renaissance Technologies, Two Sigma Investments and AQR Capital Management. See Funds
When did Harmony Biosciences Holdings last report earnings?0.81
Harmony Biosciences Holdings last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of 0.81 USD; no next date is announced in SEC filings yet. See Filings
What is Reddit saying about Harmony Biosciences Holdings?0 mentions
Harmony Biosciences Holdings was mentioned 0 times in the last 7 days across the finance subreddits we track, and 1 times over the trailing 30 days. Of the 1 mentions scored for sentiment, 100% read bullish and 0% bearish. That is a social signal, not investment advice. See Reddit
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
- TradingViewthe price chart widget, drawn by TradingView from their own data
- RedditReddit ingest across the tracked finance subreddits
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings